Johnson & Johnson at Barclays Global Healthcare Conference Transcript
Here in U.S. for Barclays. I'm very, very pleased to have with us today, J&J. From J&J, we've got Aldo Denti, Company Group Chairman of DePuy Synthes; and Peter Menziuso, Company Group Chairman of Johnson & Johnson Vision. So thanks so much, guys, for joining us today.
Thank you for having us.
Questions & Answers
So I'll try to keep you both kind of engaged and busy here. We'll hop back and forth between Vision and Ortho. Maybe starting with Orthopaedics, Aldo, so I think one of the developments over the past year has been that, let's just say, after a number of years of growing kind of at a more muted growth rate, Orthopaedics, in particular, and some of your other musculoskeletal businesses have really started to kind of lift off.
So maybe can you talk about some of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |